Results 11 to 20 of about 125,008 (257)
Research progress of mitophagy in chronic cerebral ischemia. [PDF]
Front Aging Neurosci, 2023 Chronic cerebral ischemia (CCI), a condition that can result in headaches, dizziness, cognitive decline, and stroke, is caused by a sustained decrease in cerebral blood flow. Statistics show that 70% of patients with CCI are aged > 80 years and approximately 30% are 45–50 years.
Yu M +5 more
europepmc +4 more sources
Diagnostics and treatment of chronic cerebral ischemia
Медицинский совет, 2020 5560 patients with the diagnosis “Other cerebral vascular diseases” per 100 000 of elderly population were registered in RF in 2017. Usually this is a code for chronic brain ischemia (CBI) – the most popular diagnosis in Russian neurological practice ...
V. V. Zakharov +3 more
doaj +3 more sources
Neurometabolic therapy in chronic cerebral ischemia
Лечащий ВрачBackground. On February 10-12, 2025, the XXI Interdisciplinary Congress with international participation "Vein Readings" was held in Moscow. The congress is devoted to topical issues of neurology and every year successfully brings together leading ...
E. Yu. Solovyeva +2 more
doaj +2 more sources
Tooth loss, cognitive impairment and chronic cerebral ischemia. [PDF]
J Dent Sci, 2020 Vascular factor is an important risk factor in the process of cognitive impairment or dementia. Tooth loss could cause impairments of spatial learning and memory in mice, and nitric oxide (NO) and its synthase might be involved in the process. The objectives of this study were to investigate and compare the behavioral impairments between the Wistar ...
Pang Q, Wu Q, Hu X, Zhang J, Jiang Q.
europepmc +3 more sources
Microelement composition of oral fluid in patients with chronic cerebral ischemia
Эндодонтия Today, 2023 Relevance. Today, due to the emergence of new and improvement of existing methods of laboratory diagnostics, more and more attention of researchers is directed to the study of the composition and properties of the oral fluid of a person with a history of
A. V. Mitronin +3 more
doaj +1 more source
Patologìâ, 2015 Aim. Pharmacological remodeling of pathologic changes when cerebral ischemia takes place is actual task for today. With the purpose of thiocetam neuroprotective properties studying in conditions of experimental chronic cerebral ischemia the ...
A. V. Demchenko, І. F. Belenichev
doaj +1 more source
Neural Regeneration Research, 2016 Bumetanide has been shown to lessen cerebral edema and reduce the infarct area in the acute stage of cerebral ischemia. Few studies focus on the effects of bumetanide on neuroprotection and neurogenesis in the chronic stage of cerebral ischemia.
Wang-shu Xu +6 more
doaj +1 more source
A multimodal approach in the treatment of chronic cerebral ischemia: what should a doctor know?
Медицинский совет, 2020 The article discusses one of the leading problems of modern angioneurology - chronic cerebral ischemia. The main etiological factors playing a significant role in the development of chronic cerebral ischemia, among which atherosclerosis, hypertension ...
N. V. Pizova
doaj +1 more source
Improving the management of patients with a diagnosis of chronic cerebral ischemia
Медицинский совет, 2020 The diagnosis of сhronic cerebral ischemia is widely used in domestic neurological practice. A significant part of the patients observed with a diagnosis of сhronic cerebral ischemia suffer from primary or secondary headache, dizziness of various origins,
V. A. Parfenov
doaj +1 more source
The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia [PDF]
Current Pharmaceutical Design, 2016 Kynurenines are a wide range of catabolites which derive from tryptophan through the "Kynurenine Pathway" (KP). In addition to its peripheral role, increasing evidence shows a role of the KP in the central nervous system (CNS), mediating both physiological and pathological functions.
María Isabel, Cuartero +5 more
openaire +2 more sources